Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
XLO on Nasdaq
There are no Buy or Sell transactions made by TAKEDA PHARMACEUTICAL CO LTD since 13 Feb 2025
Holdings reported by TAKEDA PHARMACEUTICAL CO LTD for Xilio Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,475,121 |
$1,224,350 |
$0.8300 |
26 Oct 2021 |
Indirect |
|
|
| Series B Preferred Stock |
0 |
|
|
26 Oct 2021 |
Indirect |
Common Stock |
|
| Series C Preferred Stock |
0 |
|
|
26 Oct 2021 |
Indirect |
Common Stock |
|
Transactions reported by TAKEDA PHARMACEUTICAL CO LTD for Xilio Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.